Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 11/20 | 0.47 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
| ▸ | CTSL | P07711 | 5/20 | 0.44 |
| ▸ | CTSB | P07858 | 3/20 | 0.44 |
| ▸ | CTSS | P25774 | 2/20 | 0.44 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.44 |
| ▸ | CAPN2 | P17655 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31005798 | 1.00 | CTSK (0.47) | CTSKTYRCTSLCTSBCTSS | |
| SCHEMBL2234378 | 1.00 | CTSK (0.47) | CTSKTYRCTSLCTSBCTSS | |
| SCHEMBL22804081 | 1.00 | CTSK (0.47) | CTSKTYRCTSLCTSBCTSS | |
| SCHEMBL27718876 | 1.00 | CTSK (0.47) | CTSKTYRCTSLCTSBCTSS | |
| SCHEMBL10630925 | 0.92 | CAPN1 (0.47) | CTSKCTSLCTSBCTSSCAPN1 | |
| SCHEMBL10658422 | 0.92 | TYR (0.41) | CTSKTYRCTSLCTSBCTSS | |
| SCHEMBL10658398 | 0.92 | TYR (0.41) | CTSKTYRCTSLCTSBCTSS | |
| SCHEMBL30367329 | 0.89 | PNMT (0.40) | CTSKTYR | |
| SCHEMBL30146700 | 0.89 | PNMT (0.42) | CTSKCAPN1CAPN2 | |
| Lysine SCHEMBL28193040 | 0.89 | ACE (0.41) | CTSKTYRCTSLCAPN1CAPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117304131-A | Alpha-carbonyl alkenyl ester compound, and preparation method and application thereof | 广州医科大学 | 2023-12-29 | — | — | CN | claimed |
| CN-113797336-B | Arginine-small peptide complex and photosensitizer co-assembled nanoparticle as well as preparation method and application thereof | 沈阳药科大学 | 2023-06-16 | — | — | CN | claimed |
| EP-4665887-A1 | PEPTIDE SELF-ASSEMBLY AS A STRATEGY FOR FACILE IMMOBILIZATION OF ENZYMES AND MICROORGANISMS ON ELECTRODES | Ramot at Tel-Aviv University Ltd. (IL) | 2025-12-24 | — | — | EP | disclosed |
| US-20250369136-A1 | PEPTIDE SELF-ASSEMBLY AS A STRATEGY FOR FACILE IMMOBILIZATION OF ENZYMES AND MICROORGANISMS ON ELECTRODES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2025-12-04 | — | — | US | disclosed |
| US-20250326798-A1 | Synthetic Process for Production of Modified GCC Receptor Agonists | IRONWOOD PHARMACEUTICALS INC (US) | 2025-10-23 | — | — | US | disclosed |
| CN-119591674-A | Cyclohexapeptide and preparation method and application thereof | 陕西未来多肽生物科技有限公司 | 2025-03-11 | — | — | CN | disclosed |
| WO-2024171188-A1 | PEPTIDE SELF-ASSEMBLY AS A STRATEGY FOR FACILE IMMOBILIZATION OF ENZYMES AND MICROORGANISMS ON ELECTRODES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2024-08-22 | — | — | WO | disclosed |
| WO-2024153243-A1 | MODIFIED PEPTIDE AS TREM-1 INHIBITOR | 武汉人福创新药物研发中心有限公司 | 2024-07-25 | — | — | WO | disclosed |
| CN-117304131-A | Alpha-carbonyl alkenyl ester compound, and preparation method and application thereof | 广州医科大学 | 2023-12-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250326798-A1 | Synthetic Process for Production of Modified GCC Receptor Agonists | GNRHR, SCTR, GIPR | CTSK 4551/4885TYR 3508/4885CTSL 3609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.